Key points are not available for this paper at this time.
. Recombinant IFN-λ pretreatment reduced RVFV protein expression, highlighting hTSCs as a robust model and IFN-λ as a promising antiviral strategy.
Share your take
Add a clinician perspective alongside expert commentary.
Gwon et al. (2026) studied this question.